Skip to main content
. 2020 Jan 30;20:40. doi: 10.1186/s12872-020-01326-2

Table 5.

Medications at baseline and 1-year follow-up [n (%)]

Medications Baseline (n = 131) 1-year follow-up (n = 126) P-value
Antiplatelet therapy 35 (26.7) 85 (67.5) < 0.001
β-blocker 28 (21.4) 68 (54.0) < 0.001
Calcium channel blockers 35 (26.7) 28 (22.2) 0.312
ACE-I/ARB 35 (26.7) 56 (44.4) 0.003
Diuretics 10 (7.6) 10 (7.9) 1
Statins 28 (21.4) 86 (68.3) < 0.001
Hypoglycemic agents 22 (16.8) 29 (23.0) 0.215

ACE-I/ARB angiotensin-converting enzyme inhibitors / angiotensin II receptor blockers